Note: Ingredients listed on restricted chemical lists
General Information
Version
1.0
Revision date
2016-07-05
Product name
Human Bone MAG Panel Human Bone Standard
REACH No
This
1.2.1 Relevant identified uses
Biochemical research/analysis For additional information on uses please refer to the Merck Chemicals
Icons in SDS
Company Information
company name
Merck KGaA
e-mail address of the competent person responsible for the Safety Data Sheet
prodsafe@merckgroup.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H318, H412
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Danger Danger
Hazard statements
H302 Harmful if swallowed. H318 Causes serious eye damage. H412 Harmful to aquatic life with long lasting effects. H318 Causes serious eye damage. H412 Harmful to aquatic life with long lasting effects.
Prevention
P273 Avoid release to the environment. P280 Wear eye protection.
Response
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P313 Get medical advice/ attention. Reduced labelling (≤125 ml)
Precautionary statements
P280 Wear eye protection. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P313 Get medical advice/ attention.
Contains
Tetrasodium ethylenediaminetetraacetate, sodium azide
2.3 Other hazards
None known.
2.1 Classification of the substance or mixture
Classification (REGULATION (EC) No 1272/2008) Acute toxicity, Category 4, Oral, H302 Serious eye damage, Category 1, H318 Chronic aquatic toxicity, Category 3, H412 For the full text of the H-Statements mentioned in this Section, see Section 16. Classification (67/548/EEC or 1999/45/EC) T Toxic R25 Xi Irritant R41 Dangerous for the environment R52/53 For the full text of the R-phrases mentioned in this Section, see Section 16.
